Variant report
Variant | nsv879593 |
---|---|
Chromosome Location | chr4:92664701-92691639 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4290865 | chr4:92664701-92664702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs372886049 | chr4:92664712-92664713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs60693432 | chr4:92664714-92664715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565208159 | chr4:92664726-92664727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144581051 | chr4:92664732-92664733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564485350 | chr4:92664760-92664761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35113240 | chr4:92664765-92664766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182136442 | chr4:92664767-92664768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187216591 | chr4:92664817-92664818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569076597 | chr4:92664832-92664833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377097616 | chr4:92664853-92664854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555629993 | chr4:92664884-92664885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10018155 | chr4:92664886-92664887 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs544177306 | chr4:92664925-92664926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557358654 | chr4:92664944-92664945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531901207 | chr4:92664990-92664991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539908531 | chr4:92665089-92665090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559825132 | chr4:92665094-92665095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551908854 | chr4:92665099-92665100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10018264 | chr4:92665111-92665112 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs537005771 | chr4:92665121-92665122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377726135 | chr4:92665123-92665124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542892136 | chr4:92665185-92665186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563179853 | chr4:92665200-92665201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550181129 | chr4:92665252-92665253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs115131899 | chr4:92665260-92665261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534168235 | chr4:92665274-92665275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142590665 | chr4:92665287-92665288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112768903 | chr4:92665317-92665318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527694613 | chr4:92665422-92665423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547862365 | chr4:92665522-92665523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs28836302 | chr4:92665601-92665602 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190838070 | chr4:92665620-92665621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548943165 | chr4:92665621-92665622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151276216 | chr4:92665646-92665647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537722848 | chr4:92665647-92665648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557647079 | chr4:92665651-92665652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577177693 | chr4:92665654-92665655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182156401 | chr4:92665668-92665669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553441981 | chr4:92665692-92665693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560532866 | chr4:92665702-92665703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112492524 | chr4:92665716-92665717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543182991 | chr4:92665805-92665806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs567859304 | chr4:92665849-92665850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187264491 | chr4:92665857-92665858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190171787 | chr4:92665863-92665864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576591748 | chr4:92665864-92665865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs183168924 | chr4:92665939-92665940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565578712 | chr4:92665994-92665995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538570229 | chr4:92666024-92666025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:92662400-92667800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr4:92666200-92666400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr4:92666400-92667600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:92667600-92667800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:92667800-92668200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr4:92668200-92668400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr4:92676400-92677400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr4:92677000-92678200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
9 | chr4:92677400-92679200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr4:92677800-92680600 | Enhancers | HUVEC | blood vessel |
11 | chr4:92678200-92679800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr4:92679000-92680200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr4:92679200-92680600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr4:92679600-92680200 | Enhancers | NH-A | brain |
15 | chr4:92679800-92680200 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr4:92679800-92680200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr4:92680000-92680400 | Enhancers | Hela-S3 | cervix |
18 | chr4:92680200-92680600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
19 | chr4:92686200-92686800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
20 | chr4:92686400-92687000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr4:92686600-92687000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
22 | chr4:92686800-92687200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |